Success Metrics

Clinical Success Rate
87.9%

Based on 29 completed trials

Completion Rate
88%(29/33)
Active Trials
24(31%)
Results Posted
31%(9 trials)
Terminated
4(5%)

Phase Distribution

Ph not_applicable
13
17%
Ph phase_2
4
5%
Ph phase_1
9
12%
Ph phase_4
1
1%
Ph early_phase_1
1
1%

Phase Distribution

10

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
9(32.1%)
Phase 2Efficacy & side effects
4(14.3%)
Phase 4Post-market surveillance
1(3.6%)
N/ANon-phased studies
13(46.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.3%

29 of 38 finished

Non-Completion Rate

23.7%

9 ended early

Currently Active

24

trials recruiting

Total Trials

78

all time

Status Distribution
Active(30)
Completed(29)
Terminated(9)
Other(10)

Detailed Status

Completed29
Recruiting18
unknown10
Active, not recruiting6
Not yet recruiting6
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
78
Active
24
Success Rate
87.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 19 (32.1%)
Phase 24 (14.3%)
Phase 41 (3.6%)
N/A13 (46.4%)

Trials by Status

terminated45%
unknown1013%
withdrawn56%
active_not_recruiting68%
not_yet_recruiting68%
completed2937%
recruiting1823%

Recent Activity

Clinical Trials (78)

Showing 20 of 78 trialsScroll for more
NCT07630402Not Applicable

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Recruiting
NCT06023576Phase 2

A Study of Blood Pressure Control During Cancer Treatment

Recruiting
NCT07132788Not Applicable

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Recruiting
NCT06652763

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

Recruiting
NCT04458883Not Applicable

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Recruiting
NCT05920824

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Recruiting
NCT07483203

A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease

Not Yet Recruiting
NCT02780128Phase 1

Next Generation Personalized Neuroblastoma Therapy

Terminated
NCT04002531Not Applicable

A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children

Completed
NCT04827563

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Terminated
NCT07438301

Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration

Not Yet Recruiting
NCT05208567

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

Recruiting
NCT05164744

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Recruiting
NCT07321405

Assessment of Cardiac Output and Stroke Volume in Septic Shock Patients

Not Yet Recruiting
NCT06927973Not Applicable

Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction

Completed
NCT03952637Phase 1

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Recruiting
NCT04713657Phase 1

Beta-blocker Administration for Cardiomyocyte Division

Recruiting
NCT04185246Phase 1

A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography

Completed
NCT07058064Not Applicable

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

Recruiting
NCT04036045

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Withdrawn

Drug Details

Intervention Type
PROCEDURE
Total Trials
78